Carlsmed, Inc. (CARL) Price & Analysis

Compare

41 Followers

CARL Stock Chart & Stats

Day’s Range― - ―

52-Week Range$11.81 - $15.20

Previous CloseN/A

VolumeN/A

Average Volume (3M)131.33K

Market Cap

N/A

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta1.93

Next Earnings

Aug 28, 2025

EPS Estimate

-0.91

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding26,581,135

10 Day Avg. Volume75,040

30 Day Avg. Volume131,331

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$18.50

Price Target Upside25.08% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering5

Bulls Say, Bears Say

Bulls Say

Market PotentialCARL is capitalizing on a ~$13.4B market opportunity, indicating a significant potential for future expansion and revenue growth.

Revenue GrowthCARL is confident in its full year revenue guide due to strong new surgeon adoption and scheduled procedure volume visibility.

Technological InnovationCarlsmed’s Aprevo Technology Platform is pioneering a new standard of care in spine fusion surgery with custom 3D printed interbody implants and AI enabled surgical planning software.

Bears Say

Future UncertaintiesCARL remains optimistic about the cervical spine ramp coming in 2026 to address unmet needs in cervical spine fusions.

Valuation ConcernsThe valuation is at the high end of other high growth medtech companies due to CARL’s high revenue growth and high gross margin profile.

Carlsmed, Inc. News

Here’s Goldman Sachs’ Next S&P 500 Target — Plus 2 Top Stock Picks

The stock markets are at record highs, having shown a solid recovery from their sharp losses in April....

3d ago

BRZE

CARL

Carlsmed reports Q2 revenue $12.1M, consensus $11.99M

Cash and cash equivalents were $33.5M as of June 30. “Our strong commercial performance was driven by the...

17d ago

CARL

Carlsmed sees FY25 revenue $45.5M-$47.5M, consensus $45.67M

The company said, “Revenue for the full year 2025 is expected to be in the range of $45.5...

17d ago

CARL

CVS Health upgraded, Occidental downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

27d ago

ARX

Carlsmed initiated with a Buy at Truist

Truist initiated coverage of Carlsmed (CARL) with a Buy rating and $18 price target The firm views Carlsmed...

27d ago

CARL

Carlsmed initiated with a Buy at BofA

BofA analyst Travis Steed initiated coverage of Carlsmed (CARL) with a Buy rating and $16 price target The...

27d ago

CARL

Carlsmed initiated with a Buy at BTIG

BTIG initiated coverage of Carlsmed (CARL) with a Buy rating and $21 price target The firm views the...

27d ago

CARL

Carlsmed initiated with an Overweight at Piper Sandler

Piper Sandler analyst Matt O’Brien initiated coverage of Carlsmed (CARL) with an Overweight rating and $18 price target...

27d ago

CARL

Carlsmed initiated with a Buy at Goldman Sachs

Goldman Sachs analyst David Roman initiated coverage of Carlsmed (CARL) with a Buy rating and $19 price target...

28d ago

CARL

Carlsmed, Inc.: Strong Financial Performance and Growth Potential Justify Buy Rating

BTIG analyst Ryan Zimmerman has maintained their bullish stance on CARL stock, giving a Buy rating today. Ryan...

16d ago

CARL

Carlsmed, Inc.: Strong Performance and Promising Growth Prospects with Upcoming Product Launch

Analyst Travis Steed from Bank of America Securities reiterated a Buy rating on Carlsmed, Inc. and keeping the...

16d ago

CARL

Carlsmed Reports Strong Growth in Q2 2025 Earnings

Carlsmed, Inc. ( ($CARL) ) has released its Q2 earnings. Here is a breakdown of the information Carlsmed,...

17d ago

CARL

Buy Rating for Carlsmed: Innovative Aprevo Technology and Strong Growth Projections Justify Premium Valuation

Carlsmed, Inc. (CARL) has received a new Buy rating, initiated by Bank of America Securities analyst, Travis Steed....

27d ago

CARL

Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures

Carlsmed (CARL), announced that in the Hospital Inpatient Prospective Payment Systems Final Rule for fiscal year 2026, the...

1M ago

CARL

CARL FAQ

What was Carlsmed, Inc.’s price range in the past 12 months?

Carlsmed, Inc. lowest stock price was $11.81 and its highest was $15.20 in the past 12 months.

What is Carlsmed, Inc.’s market cap?

Currently, no data Available

When is Carlsmed, Inc.’s upcoming earnings report date?

Carlsmed, Inc.’s upcoming earnings report date is Aug 28, 2025 which is 17 days ago.

How were Carlsmed, Inc.’s earnings last quarter?

Carlsmed, Inc. released its earnings results on Aug 28, 2025. The company reported -$1.47 earnings per share for the quarter, missing the consensus estimate of -$0.914 by -$0.556.

Is Carlsmed, Inc. overvalued?

According to Wall Street analysts Carlsmed, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Carlsmed, Inc. pay dividends?

Carlsmed, Inc. does not currently pay dividends.

What is Carlsmed, Inc.’s EPS estimate?

Carlsmed, Inc.’s EPS estimate is -0.91.

How many shares outstanding does Carlsmed, Inc. have?

Carlsmed, Inc. has 26,581,135 shares outstanding.

What happened to Carlsmed, Inc.’s price movement after its last earnings report?

Carlsmed, Inc. reported an EPS of -$1.47 in its last earnings report, missing expectations of -$0.914. Following the earnings report the stock price went down -2.849%.

Which hedge fund is a major shareholder of Carlsmed, Inc.?

Currently, no hedge funds are holding shares in CARL

Carlsmed, Inc. (CARL) Earnings & Revenues

Historic Earnings Reports

CARL Earnings Call

Q2 2025

0:00 / 0:00

CARL Stock 12 Month Forecast

Average Price Target

$18.50

▲(25.08% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","17":"$17","22":"$22","14.5":"$14.5","19.5":"$19.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$21.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$18.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$16.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,14.5,17,19.5,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.6,14.169230769230769,14.738461538461538,15.307692307692307,15.876923076923077,16.446153846153845,17.015384615384615,17.584615384615383,18.153846153846153,18.723076923076924,19.29230769230769,19.861538461538462,20.43076923076923,{"y":21,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.6,13.976923076923077,14.353846153846154,14.73076923076923,15.107692307692307,15.484615384615385,15.861538461538462,16.23846153846154,16.615384615384617,16.99230769230769,17.369230769230768,17.746153846153845,18.123076923076923,{"y":18.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.6,13.784615384615384,13.96923076923077,14.153846153846153,14.338461538461539,14.523076923076923,14.707692307692307,14.892307692307693,15.076923076923077,15.26153846153846,15.446153846153846,15.63076923076923,15.815384615384616,{"y":16,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.45,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.45,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.45,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.45,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.45,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.45,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.45,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.45,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.45,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.45,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.45,"date":1751328000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.6,"date":1754006400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >